This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/521245-india-covid-covaxin-production/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
India aiming to produce 100 million doses of home-grown Covaxin Covid-19 jab per month by September India aiming to produce 100 million doses of home-grown Covaxin Covid-19 jab per month by September
(about 1 month later)
India is pushing to greatly expand production of its home-grown Covaxin jab and expects to hit the rate of some 100 million doses per month by September. The country has experienced a sharp increase in new Covid-19 cases lately.India is pushing to greatly expand production of its home-grown Covaxin jab and expects to hit the rate of some 100 million doses per month by September. The country has experienced a sharp increase in new Covid-19 cases lately.
Currently, India makes around 10 million doses of Bharat Biotech’s jab, the country’s Ministry of Science & Technology said in a statement on Friday. The manufacturing level is set to change in the months to come, with output expected to grow sharply as a result.Currently, India makes around 10 million doses of Bharat Biotech’s jab, the country’s Ministry of Science & Technology said in a statement on Friday. The manufacturing level is set to change in the months to come, with output expected to grow sharply as a result.
“The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly six-, seven-fold by July-August 2021,” the ministry said.“The current production capacity of indigenously developed Covaxin vaccine will be doubled by May-June 2021 and then increased nearly six-, seven-fold by July-August 2021,” the ministry said.
Earlier in the day, state-run Haffkine Bio-Pharmaceutical said it has also been contracted to produce Bharat Biotech's jab. The Mumbai-based company said it expects to manufacture some 228 million per annum, though setting up the production line is expected to take at least a year.Earlier in the day, state-run Haffkine Bio-Pharmaceutical said it has also been contracted to produce Bharat Biotech's jab. The Mumbai-based company said it expects to manufacture some 228 million per annum, though setting up the production line is expected to take at least a year.
“A proposal was submitted in January this year owing to the rising cases of coronavirus and need for more vaccines to immunize a large number of people. It is an ambitious project which is important from the angle of vaccination of such a large population,” Haffkine Bio-Pharmaceutical said.“A proposal was submitted in January this year owing to the rising cases of coronavirus and need for more vaccines to immunize a large number of people. It is an ambitious project which is important from the angle of vaccination of such a large population,” Haffkine Bio-Pharmaceutical said.
India is enduring a severe new wave of coronavirus infections. Over the past nine days, the country registered eight record daily increases. The latest was set on Friday, with more than 217,000 new cases reported by the health ministry.India is enduring a severe new wave of coronavirus infections. Over the past nine days, the country registered eight record daily increases. The latest was set on Friday, with more than 217,000 new cases reported by the health ministry.
The country’s death toll grew by 1,185 over the past 24 hours, marking the deadliest day in over seven months. Some parts of India have reintroduced lockdown measures in an attempt to contain the spread of the virus.The country’s death toll grew by 1,185 over the past 24 hours, marking the deadliest day in over seven months. Some parts of India have reintroduced lockdown measures in an attempt to contain the spread of the virus.
India is the second worst coronavirus-hit nation in the world in terms of absolute figures, with nearly 14.3 million Covid-19 cases registered since the beginning of the pandemic. The country’s tally is dwarfed only by the US, which is approaching the 31.5 million-cases mark.India is the second worst coronavirus-hit nation in the world in terms of absolute figures, with nearly 14.3 million Covid-19 cases registered since the beginning of the pandemic. The country’s tally is dwarfed only by the US, which is approaching the 31.5 million-cases mark.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.